We estimate that the CEO of Roivant Sciences Ltd. ($ROIV), Matthew Gline, received a compensation of $3,096,190 in 2025. This is a decrease of -5,174.02% from an estimated $163,293,744 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on July 29, 2026. Note that parsing errors may occur.
You can track $ROIV on Quiver Quantitative's $ROIV stock dashboard.
$ROIV Stock Insider Trading Activity
$ROIV Stock insiders have traded $ROIV stock on the open market 51 times in the past 6 months. Of those trades, 0 have been purchases and 51 have been sales.
Here’s a breakdown of recent trading of $ROIV stock by insiders over the last 6 months:
- KEITH S MANCHESTER has made 0 purchases and 11 sales selling 2,863,947 shares for an estimated $89,102,593.
- FRANK TORTI (President and Vant Chair) has made 0 purchases and 3 sales selling 3,000,000 shares for an estimated $82,039,460.
- FINANCIAL LP QVT has made 0 purchases and 10 sales selling 2,663,947 shares for an estimated $82,012,593.
- DANIEL ALLEN GOLD has made 0 purchases and 10 sales selling 2,663,947 shares for an estimated $82,012,593.
- MAYUKH SUKHATME (President & CIO) has made 0 purchases and 3 sales selling 1,339,441 shares for an estimated $43,090,003.
- ERIC VENKER (President & Immunovant CEO) has made 0 purchases and 7 sales selling 1,200,000 shares for an estimated $36,539,267.
- MATTHEW GLINE (CEO) sold 289,774 shares for an estimated $8,449,809
- MEGHAN FITZGERALD has made 0 purchases and 2 sales selling 80,000 shares for an estimated $2,270,500.
- MELISSA B, EPPERLY has made 0 purchases and 3 sales selling 59,611 shares for an estimated $1,810,825.
- JENNIFER HUMES (Chief Accounting Officer) sold 13,538 shares for an estimated $384,073
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ROIV Stock Hedge Fund Activity
We have seen 256 institutional investors add shares of $ROIV Stock stock to their portfolio, and 153 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SB INVESTMENT ADVISERS (UK) LTD removed 13,741,871 shares (-83.7%) from their portfolio in Q1 2026, for an estimated $380,649,826
- FMR LLC added 12,201,789 shares (+18.5%) to their portfolio in Q1 2026, for an estimated $337,989,555
- FARALLON CAPITAL MANAGEMENT LLC added 9,638,000 shares (+26048.6%) to their portfolio in Q1 2026, for an estimated $266,972,600
- DARWIN GLOBAL MANAGEMENT, LTD. added 6,797,300 shares (+inf%) to their portfolio in Q1 2026, for an estimated $188,285,210
- MORGAN STANLEY removed 6,531,228 shares (-11.2%) from their portfolio in Q1 2026, for an estimated $180,915,015
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 5,561,714 shares (+76.9%) to their portfolio in Q1 2026, for an estimated $154,059,477
- AQR CAPITAL MANAGEMENT LLC added 5,066,085 shares (+575.2%) to their portfolio in Q1 2026, for an estimated $140,330,554
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$ROIV Stock Analyst Ratings
Wall Street analysts have issued reports on $ROIV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 02/10/2026
To track analyst ratings and price targets for $ROIV Stock, check out Quiver Quantitative's $ROIV forecast page.
$ROIV Stock Price Targets
Multiple analysts have issued price targets for $ROIV recently. We have seen 5 analysts offer price targets for $ROIV in the last 6 months, with a median target of $40.0.
Here are some recent targets:
- Yatin Suneja from Guggenheim set a target price of $36.0 on 05/26/2026
- Douglas Tsao from HC Wainwright & Co. set a target price of $34.0 on 05/21/2026
- Yaron Werber from TD Cowen set a target price of $41.0 on 05/21/2026
- Samantha Semenkow from Citigroup set a target price of $42.0 on 05/21/2026
- Yasmeen Rahimi from Piper Sandler set a target price of $40.0 on 04/16/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
